Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine in a large, double-blind, randomized, prospective
pediatric clinical trial whether the use of continuous levalbuterol (Xopenex) in addition to
standard emergency department treatment for acute asthma exacerbations will improve the
Forced Expiratory Volume in 1 sec (FEV 1) compared to the use of continuous racemic
albuterol. The secondary objective is to correlate clinical (hospitalization rates and
clinical asthma scores) with plasma levels of (S)-albuterol.